Coronary heart disease (CHD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years; 2. Patients who were clearly diagnosed with coronary heart disease [5] and received elective PCI within two weeks after surgery; 3. It meets the syndrome differentiation standard of TCM qi deficiency and blood stasis [6]; 4. Sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Subjects who have participated in other drug clinical trials or interventional studies within 30 days; 2. Serious arrhythmia, severe disorders of cardiopulmonary function (? heart function class, 4 severely abnormal lung function); 3. Patients with poor hypertension control (systolic blood pressure 160mmHg or diastolic blood pressure 100mmHg after treatment); 4. Patients with severe liver and kidney function impairment (ALT, AST or TBIL>2 times the upper limit of normal reference value, or Cr > 1.5 times the upper limit of normal reference value); 5. Patients with severe primary diseases or mental diseases such as hematopoietic system; 6. Allergic constitution or allergy to known components of the study drugs; 7. According to the judgment of the researcher, the subject is not suitable for study observation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular related deaths;Nonfatal myocardial infarction;Revascularization;Nonfatal stroke;Number of readmissions and number of admissions due to angina within one year; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of readmissions due to cardiovascular events;Anginal frequency and angina pectoris score;Chinese medicine symptom complex score;Seattle angina scale score;PHQ-9?GAD-7scale;Echocardiography;NT-proBNP;Biochemical examination;Hs-CRP; | — |
Countries
China
Contacts
Department of Traditional Chinese Medicine, Fuwai Hospital